Halozyme Therapeutics Inc. logo

Halozyme Therapeutics Inc. (HALO)

Market Closed
23 Feb, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
70. 64
-0.34
-0.48%
$
8.35B Market Cap
20.87 P/E Ratio
- Div Yield
1,437,729 Volume
2.74 Eps
$ 70.98
Previous Close
Day Range
69.8 71.33
Year Range
47.5 82.22
Want to track HALO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
HALO earnings report is expected in 70 days (5 May 2026)
Name Time Cons. EPS Eps
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
12 May 2026 (In 2 months)
1.76
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
5 May 2026 (In 2 months)
1.66
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
24 Feb 2026
1.9
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
17 Feb 2026
2.15
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
3 Nov 2025
1.63
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
29 Oct 2025
1.43
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
28 Oct 2025
1.61
1.72
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
12 Aug 2025
1.24
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
5 May 2025
0.97
1.11
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
18 Feb 2025
1.16
1.26
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
4 Nov 2024
0.98
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
6 Aug 2024
0.76
0.91
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
7 May 2024
0.7
0.79
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
19 Feb 2024
0.83
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
6 Nov 2023
0.71
0.75
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
7 Nov 2016
-
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
9 Aug 2016
-
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
9 May 2016
-
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
29 Feb 2016
-
0.03
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
9 Nov 2015
-
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
10 Aug 2015
-
0.02
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
11 May 2015
-
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
2 Mar 2015
-
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
10 Nov 2014
-
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
11 Aug 2014
-
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
12 May 2014
-
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
27 Feb 2014
-
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
8 Nov 2013
-
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
7 Aug 2013
-
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
8 May 2013
-
-
Halozyme Therapeutics Inc. logo
HALO Halozyme Therapeutics Inc.
25 Feb 2013
-
-

HALO Earnings Reports FAQ

What is the earnings per share (EPS) for HALO?

The current EPS is 2.74.

What is the company's earnings growth rate?

Over the past 13 years, the earnings growth rate has been approximately 56.12%, reflecting the HALO's performance and NASDAQ (NGS) market conditions.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-24, based on the HALO's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Halozyme Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for HALO at this time, as Halozyme Therapeutics Inc has no recent EPS data to calculate it.